MTP930B - Substained release lithium-containing tablets and method for their manufacture - Google Patents
Substained release lithium-containing tablets and method for their manufactureInfo
- Publication number
- MTP930B MTP930B MT930A MTP930A MTP930B MT P930 B MTP930 B MT P930B MT 930 A MT930 A MT 930A MT P930 A MTP930 A MT P930A MT P930 B MTP930 B MT P930B
- Authority
- MT
- Malta
- Prior art keywords
- tablets
- granulate
- lithium carbonate
- sustained release
- manufacture
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 title 1
- 229910052744 lithium Inorganic materials 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000002245 particle Substances 0.000 abstract 3
- 239000008187 granular material Substances 0.000 abstract 2
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 abstract 2
- 229910052808 lithium carbonate Inorganic materials 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 238000013268 sustained release Methods 0.000 abstract 2
- 239000012730 sustained-release form Substances 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000009481 moist granulation Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 125000005472 straight-chain saturated fatty acid group Chemical group 0.000 abstract 1
- 150000005691 triesters Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The release pattern of sustained release lithium carbonate tablets is improved by using a particular form of lithium carbonate material. This should have acicular crystals with a substantially monomodal particle size distribution in which the curve showing volume percentages of particles of different sizes shows a peak at a particle diameter of between 10 and 25 mu m. Moreover not more than 20% by volume of the material should have a particular diameter above 30 mu m. A preferred sustained release agent is a mixture of glyceryl mono-di- and tri-esters of straight chain saturated fatty acids. The tablets may be made by a moist granulation technique, followed by screening to ensure a granulate of appropriate grain sizes, after which the granulate is compacted into tablets.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8212636 | 1982-04-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MTP930B true MTP930B (en) | 1984-04-10 |
Family
ID=10530100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MT930A MTP930B (en) | 1982-04-30 | 1983-04-18 | Substained release lithium-containing tablets and method for their manufacture |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0093538B1 (en) |
| AT (1) | ATE15760T1 (en) |
| AU (1) | AU551212B2 (en) |
| CA (1) | CA1200502A (en) |
| CY (1) | CY1356A (en) |
| DE (1) | DE3360873D1 (en) |
| EG (1) | EG17257A (en) |
| GB (1) | GB2119247B (en) |
| GR (1) | GR78843B (en) |
| IL (1) | IL68482A (en) |
| MT (1) | MTP930B (en) |
| NZ (1) | NZ203959A (en) |
| PT (1) | PT76567B (en) |
| ZA (1) | ZA832799B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8730011D0 (en) * | 1987-12-23 | 1988-02-03 | Smithkline Dauelsberg | Pharmaceutical compositions |
| GB8809421D0 (en) * | 1988-04-21 | 1988-05-25 | Fordonal Sa | Antacid compositions with prolonged gastric residence time |
| GB9018839D0 (en) * | 1990-08-29 | 1990-10-10 | Newton John M | Slow release compositions |
| FR2740342B1 (en) * | 1995-10-26 | 1997-12-19 | Oreal | USE OF LANTHANIDE, MANGANESE, LITHIUM, TIN, ZINC OR YTTRIUM SALT, COBALT, BARIUM, STRONTIUM IN PHARMACEUTICAL COMPOSITIONS |
| GB9806462D0 (en) * | 1998-03-26 | 1998-05-27 | Glaxo Group Ltd | Improved compositions for inhalation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1209093A (en) * | 1968-07-16 | 1970-10-14 | Delandale Lab Ltd | Pharmaceutical preparation |
| GB1450536A (en) * | 1972-11-27 | 1976-09-22 | Delandale Lab Ltd | Method of making tablets |
| GB2016922B (en) * | 1978-02-17 | 1982-08-18 | Delandale Lab Ltd | Sustained release lithium carbonate tables |
-
1983
- 1983-04-18 MT MT930A patent/MTP930B/en unknown
- 1983-04-19 DE DE8383302216T patent/DE3360873D1/en not_active Expired
- 1983-04-19 GB GB08310535A patent/GB2119247B/en not_active Expired
- 1983-04-19 PT PT76567A patent/PT76567B/en unknown
- 1983-04-19 CY CY135683A patent/CY1356A/en unknown
- 1983-04-19 EP EP83302216A patent/EP0093538B1/en not_active Expired
- 1983-04-19 AT AT83302216T patent/ATE15760T1/en not_active IP Right Cessation
- 1983-04-20 NZ NZ203959A patent/NZ203959A/en unknown
- 1983-04-20 CA CA000426260A patent/CA1200502A/en not_active Expired
- 1983-04-21 ZA ZA832799A patent/ZA832799B/en unknown
- 1983-04-22 AU AU13879/83A patent/AU551212B2/en not_active Expired
- 1983-04-25 IL IL68482A patent/IL68482A/en not_active IP Right Cessation
- 1983-04-25 GR GR71189A patent/GR78843B/el unknown
- 1983-04-30 EG EG267/83A patent/EG17257A/en active
Also Published As
| Publication number | Publication date |
|---|---|
| GR78843B (en) | 1984-10-02 |
| IL68482A (en) | 1986-12-31 |
| AU1387983A (en) | 1983-11-03 |
| AU551212B2 (en) | 1986-04-17 |
| PT76567B (en) | 1985-12-10 |
| EP0093538A1 (en) | 1983-11-09 |
| NZ203959A (en) | 1985-10-11 |
| IL68482A0 (en) | 1983-07-31 |
| EG17257A (en) | 1991-03-30 |
| ZA832799B (en) | 1984-01-25 |
| CY1356A (en) | 1987-08-07 |
| CA1200502A (en) | 1986-02-11 |
| EP0093538B1 (en) | 1985-09-25 |
| PT76567A (en) | 1983-05-01 |
| GB2119247A (en) | 1983-11-16 |
| GB8310535D0 (en) | 1983-05-25 |
| DE3360873D1 (en) | 1985-10-31 |
| GB2119247B (en) | 1985-08-07 |
| ATE15760T1 (en) | 1985-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT99245A (en) | Process for the preparation of a substance in the granular form containing in particular a salt of azido-bissalicylic acid and of a pharmaceutical composition comprising | |
| JPS5642550A (en) | Preparation of moderately moistened feed having high storability | |
| DE3360873D1 (en) | Sustained release lithium-containing tablets and method for their manufacture | |
| US3820970A (en) | Less dusty granular gypsum product and process | |
| JPS5215498A (en) | Process for production of granular corrundum | |
| JPS5521581A (en) | Method of manufacturing material for sintered mineral | |
| JPS53131215A (en) | Granulating method | |
| US6531167B1 (en) | Process for preparation of nutritional supplement for animals | |
| BR9100512A (en) | PROCESS FOR THE PREPARATION OF PEROXOBORATE AGGLOMERATES AND PEROXOBORATE AGGLOMERATES | |
| JPS5549863A (en) | Manufacturing method for alkaline manganese battery | |
| JPS5756330A (en) | Hexagonal ferrite powder | |
| JPS56115387A (en) | Liquefaction of coal | |
| IE38550L (en) | Method of making tablets | |
| JPS56100624A (en) | Production of granules | |
| JPS543954A (en) | Method of and apparatus for controlling particle shape of crushed material | |
| JPS55139484A (en) | Novel soil material comprising hearth waste | |
| JPS51116179A (en) | Pellets and a process for producing the same | |
| JPS51126975A (en) | A method of agglomerating and granulating fine powder material | |
| JPS5636593A (en) | Granule of pulverized coke | |
| GB2023109A (en) | Phosphate fertilizers and process for preparing them | |
| JPS5391001A (en) | Control method for raw material particle size distribution in sintering pallet | |
| JPS5753587A (en) | Preparation of dried charged coal | |
| JPS5430204A (en) | Charging of coke and other materials into dry cooling equipment | |
| JPS53113848A (en) | Preparation of composite material | |
| JPS6096592A (en) | Pelletization of powdery magnesia lime and powdery calcium carbonate |